These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 40676)

  • 1. [Lithium modifications of the cataleptogenic properties of various neuroleptic drugs in the rat].
    Dessaigne S; Scotto AM; Guigues M
    C R Seances Soc Biol Fil; 1978; 172(6):1173-80. PubMed ID: 40676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modification, by lithium, of catalepsy induced by central cholinergic stimulants and morphine-like drugs].
    Scotto di Tella AM
    C R Seances Soc Biol Fil; 1981; 175(3):357-63. PubMed ID: 6268258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of cataleptogenic effects of neuroleptics by prostaglandins.
    Herman ZS; Słomińska-Zurek J; Kryk A; Kmieciak-Kołada K
    Pol J Pharmacol Pharm; 1978; 30(5):639-46. PubMed ID: 35782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha-methyl-p-tyrosine on neuroleptic-induced catalepsy in rat.
    Gada VP; Nandal NV; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1983; 27(3):241-4. PubMed ID: 6141998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol-induced catalepsy is influenced by calcium channel antagonists.
    Biała G
    Acta Pol Pharm; 2000; 57(3):233-7. PubMed ID: 11143713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of alpha-adrenergic drugs on catalepsy induced by haloperidol or fluphenazine in rats.
    Wielosz M; Kleinrok Z; Włoch K; Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1978; 30(5):653-8. PubMed ID: 35783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epinephrine potentiates antipsychotic, but not cataleptogenic effect of haloperidol in rats.
    Gmiro VE; Serdyuk SE
    Bull Exp Biol Med; 2007 May; 143(5):617-9. PubMed ID: 18239784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cataleptogenic effect of haloperidol, chlorpromazine and morphine in developing rats.
    Brus R; Krzemiński T; Piguła J
    Pol J Pharmacol Pharm; 1983; 35(5):377-82. PubMed ID: 6686676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Farnesol and neuroleptics. I. Reinforcement by farnesol of the experimental cataleptigenic effect of neuroleptics].
    Binet P; Miocque M; Roux M; Rinjard P
    Ann Pharm Fr; 1975 May; 33(5):229-34. PubMed ID: 1239975
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stress effect on haloperidol-induced catalepsy and its circadian rhythm in intact and ovariectomized female rats].
    Baturin VA; Manvelian ÉA; Bulgakova MD
    Eksp Klin Farmakol; 2012; 75(5):3-6. PubMed ID: 22834120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seasonal changes in the behavioral effects of neuroleptics on white rats].
    Otter MIa; Kalda EI; Erik IuP
    Biull Eksp Biol Med; 1986 Nov; 102(11):577-9. PubMed ID: 2877693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of the genotype in the cataleptogenic effect of neuroleptics].
    Skrinskaia IuA; Nikulina EM; Popova NK
    Eksp Klin Farmakol; 1992; 55(6):7-9. PubMed ID: 1363957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of neuroleptic catalepsy by single or repeated administration of thiamine].
    Auclair M; Auclair MC; Thevenot R
    Med Pharmacol Exp Int J Exp Med; 1967; 16(6):545-51. PubMed ID: 4383224
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased tolerance of the dopamine- and serotoninergic systems during chronic administration of haloperidol and levomepromazine].
    Allikmets LKh; Zharkovskiĭ AM; Otter MIa; Khinrikus TKh
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1979; 29(5):1067-70. PubMed ID: 573939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
    Klemm WR
    Pharmacol Biochem Behav; 1985 Dec; 23(6):911-5. PubMed ID: 2867564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of serotonergic agents on neuroleptic induced catalepsy in rats.
    Rao SG; Hrishikeshavan HJ; Guruswami MN
    Funct Neurol; 1990; 5(4):353-60. PubMed ID: 1982664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The neuroleptic efficiency of some butyrophenone and fluorinated phenothiazine derivatives (author's transl)].
    Bekemeier H; Krause E
    Pharmazie; 1980; 35(10):634-7. PubMed ID: 6109310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of neuroleptics on foot-pedal self stimulation from the ventral tegmentum mesencephali in rats and its correlation with cataleptogenic action].
    Talalaenko AN; Boreĭsha IK; Zin'kovskaia LIa
    Farmakol Toksikol; 1982; 45(2):19-22. PubMed ID: 6122595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.